🇺🇸 Capox in United States

56 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 56

Most-reported reactions

1. Death — 10 reports (17.86%)
2. Anastomotic Leak — 7 reports (12.5%)
3. Short-Bowel Syndrome — 6 reports (10.71%)
4. Abdominal Pain — 5 reports (8.93%)
5. Colorectal Cancer Metastatic — 5 reports (8.93%)
6. Hepatic Lesion — 5 reports (8.93%)
7. Impaired Gastric Emptying — 5 reports (8.93%)
8. Lymphadenopathy — 5 reports (8.93%)
9. Metastases To Lung — 4 reports (7.14%)
10. Neoplasm Malignant — 4 reports (7.14%)

Source database →

Frequently asked questions

Is Capox approved in United States?

Capox does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Capox in United States?

Canadian Cancer Trials Group is the originator. The local marketing authorisation holder may differ — check the official source linked above.